OpenLegislation

Regulation 5 Revocations, savings and transitional provisions relating to infant formula and follow-on formulaI1

England and Wales

(1)

The instruments specified in column 1 of the table in Schedule 3 are revoked to the extent specified in column 3 of that table, subject to paragraph (2).

(2)

The instruments specified in column 1 of the table in Schedule 3 continue to have effect (so far as otherwise revoked to the extent specified in column 3 of that table)—

(a)

until 21st February F12022 in respect of infant formula and follow-on formula manufactured from protein hydrolysates;

(b)

for the purposes of paragraph (3)(b).

(3)

Infant formula and follow-on formula which does not comply with a specified EU law requirement may continue to be marketed until stocks of such food are exhausted, provided that—

(a)

it was placed on the market or labelled—

(i)

before 22nd February 2020; or

(ii)

before 22nd February F22022 in the case of infant formula and follow-on formula manufactured from protein hydrolysates; and

(b)

the conditions specified in the following provision of the Infant Formula and Follow-on Formula (England) Regulations 2007 M1 are met—

(i)

regulation 3(1) (prohibition on the marketing of infant formula unless certain conditions are met) in the case of infant formula;

(ii)

regulation 3(2) (prohibition on the marketing of follow-on formula unless certain conditions are met) in the case of follow-on formula.

Annotations

Textual amendments

F1

Word in reg. 5(2)(a) substituted (21.2.2021) by The Nutrition (Amendment) and Food for Specific Groups (Food for Special Medical Purposes for Infants, Infant Formula and Follow-on Formula) (Information and Compositional Requirements) (Amendment) Regulations 2021 (S.I. 2021/168), regs. 1(2), 2(3)(a)

F2

Word in reg. 5(3)(a)(ii) substituted (21.2.2021) by The Nutrition (Amendment) and Food for Specific Groups (Food for Special Medical Purposes for Infants, Infant Formula and Follow-on Formula) (Information and Compositional Requirements) (Amendment) Regulations 2021 (S.I. 2021/168), regs. 1(2), 2(3)(b)

Marginal citations

M1

S.I. 2007/3521, the relevant amending instrument is S.I. 2008/2445.

Commencement

I1

Reg. 5 in force at 22.2.2020, see reg. 1(1)